These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36691245)

  • 21. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of acupuncture and moxibustion combined with western medicine for obsessive-compulsive disorder: A protocol for systematic review and meta-analysis.
    Tian C; Fan Y; Xu J; Huang Y; Wang W; Wang S; Song R; Li X
    Medicine (Baltimore); 2020 Aug; 99(35):e21395. PubMed ID: 32871865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial.
    Zimmermann S; Thomas BC; Krisam J; Limprecht R; Klose C; Stenger M; Pourbaix M; Ries M; Vollstaedt-Klein S; Koopmann A; Lenz B; Kiefer F; Bach P
    BMJ Open; 2022 Apr; 12(4):e059672. PubMed ID: 35410938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
    Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Carvalho AC; Moreira J; Cubelo P; Cantista P; Branco CA; Guimarães B
    Trials; 2021 Apr; 22(1):268. PubMed ID: 33845878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.
    Mouti A; Reddihough D; Marraffa C; Hazell P; Wray J; Lee K; Kohn M
    Trials; 2014 Jun; 15():230. PubMed ID: 24934401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Plasma Oxytocin Levels in Men With Hypersexual Disorder.
    Flanagan J; Chatzittofis A; Boström ADE; Hallberg J; Öberg KG; Arver S; Jokinen J
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1816-e1822. PubMed ID: 35108393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural and clinical changes of cognitive behavioural therapy versus talking control in patients with major depression: a study protocol for a randomised clinical trial.
    Katayama N; Nakagawa A; Kurata C; Sasaki Y; Mitsuda D; Nakao S; Mizuno S; Ozawa M; Nakagawa Y; Ishikawa N; Umeda S; Terasawa Y; Tabuchi H; Kikuchi T; Abe T; Mimura M
    BMJ Open; 2020 Feb; 10(2):e029735. PubMed ID: 32102803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies.
    Raymond NC; Grant JE; Kim SW; Coleman E
    Int Clin Psychopharmacol; 2002 Jul; 17(4):201-5. PubMed ID: 12131605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
    Rana F; Gormez A; Varghese S
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009084. PubMed ID: 23633366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
    Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
    JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-generation antidepressants for treatment of seasonal affective disorder.
    Nussbaumer-Streit B; Thaler K; Chapman A; Probst T; Winkler D; Sönnichsen A; Gaynes BN; Gartlehner G
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD008591. PubMed ID: 33661528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.
    Lu W; Jiang GR;
    BMJ Open; 2018 Jul; 8(7):e022169. PubMed ID: 30056391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated model to assess and treat compulsive sexual behaviour disorder.
    Briken P
    Nat Rev Urol; 2020 Jul; 17(7):391-406. PubMed ID: 32561865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
    Olagunju A; Fowotade A; Olagunoye A; Ojo TO; Adefuye BO; Fagbamigbe AF; Adebiyi AO; Olagunju OI; Ladipo OT; Akinloye A; Adeagbo BA; Onayade A; Bolaji OO; Happi C; Rannard S; Owen A
    Trials; 2021 Jan; 22(1):3. PubMed ID: 33397457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.